Skip to main content
Top
Published in: Aesthetic Plastic Surgery 5/2018

01-10-2018 | Original Article

Muscle Insertion and Strength of the Muscle Contraction as Guidelines to Enhance Duration of the Botulinum Toxin Effect in the Upper Face

Author: Antonio Carlos Abramo

Published in: Aesthetic Plastic Surgery | Issue 5/2018

Login to get access

Abstract

Background

In this series of patients the cutaneous insertion and strength of voluntary contraction of the muscles in the upper third of the face were used as guidelines for botulinum toxin application named “BTA Codes.”

Method

Anatomical dissection of fresh cadavers identified the shape and cutaneous insertions of the muscles in the upper third of the face. Patient voluntary contraction of the muscles in the upper third of the face created different patterns of skin lines classified by the 4-grade Facial Wrinkle Scale. For botulinum toxin application injections points followed the muscle cutaneous insertion and dose the 4-grade Facial Wrinkle Scale.

Results

Injection points ranged from 3 to 23 points per patient, average of 9.4 points. Dose per point varied from 2.5 to 7.5 U, ranging from 12.5 to 72.5 U per patient, average of 33.82 U. Skin lines resulting from the voluntary contraction of the muscle prior to toxin application were stated as baseline 1. The absence of skin lines and muscle activity on day fifteen after toxin application defined baseline 2. Skin lines resulting from the recovered voluntary contraction of the muscle after toxin application like those of baseline 1 established baseline 3. The botulinum toxin effect was the time elapsed between baselines 2 and 3, ranging from 171 to 204 days, average of 183.72 days, greater than the 3 or 4 months reported in the literature.

Conclusion

“BTA Codes” is a set of rules to apply botulinum toxin supported by muscle anatomy and degree of voluntary contraction to enhance the duration of its effect.

Level of Evidence IV

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.​springer.​com/​00266.
Literature
1.
go back to reference Abramo AC (1995) Anatomy of the forehead muscles: the basis for the video-endoscopic approach in forehead rhytidoplasty. Plast Reconstr Surg 95(6):1170–1177CrossRefPubMed Abramo AC (1995) Anatomy of the forehead muscles: the basis for the video-endoscopic approach in forehead rhytidoplasty. Plast Reconstr Surg 95(6):1170–1177CrossRefPubMed
2.
go back to reference Abramo AC, do Amaral TPA, Lessio BP, de Lima GA (2016) Anatomy of forehead, glabellar, nasal and orbital muscles, and their correlation with distinctive patterns of skin lines on the upper third of the face: reviewing concepts. Aesth Plast Surg 40(6):962–971CrossRef Abramo AC, do Amaral TPA, Lessio BP, de Lima GA (2016) Anatomy of forehead, glabellar, nasal and orbital muscles, and their correlation with distinctive patterns of skin lines on the upper third of the face: reviewing concepts. Aesth Plast Surg 40(6):962–971CrossRef
3.
go back to reference Trévidic P, Sykes J, Criollo-Lamilla G (2015) Anatomy of the lower face and botulinum toxin injections. Plast Reconstr Surg 136(5S):84S–91SCrossRefPubMed Trévidic P, Sykes J, Criollo-Lamilla G (2015) Anatomy of the lower face and botulinum toxin injections. Plast Reconstr Surg 136(5S):84S–91SCrossRefPubMed
4.
go back to reference Guerrerosantos J, Eduardo PGC, Arriola JM, Manzano AIV, Villarán-Muñoz B, Benavides LG, Vazquez MG (2015) Effectiveness of botulinum toxin (type-A) administered by the fixed-site dosing approach versus the muscle area identification. Aesth Plast Surg 39(2):243–251CrossRef Guerrerosantos J, Eduardo PGC, Arriola JM, Manzano AIV, Villarán-Muñoz B, Benavides LG, Vazquez MG (2015) Effectiveness of botulinum toxin (type-A) administered by the fixed-site dosing approach versus the muscle area identification. Aesth Plast Surg 39(2):243–251CrossRef
5.
go back to reference Sundaram H, Liew S, Signorini M et al (2016) Global aesthetics consensus: hyaluronic acid fillers and botulinum toxin type A—recommendations for combined treatment and optimizing outcomes in diverse patient population. Plast Reconstr Surg 137:1410–1423CrossRefPubMedPubMedCentral Sundaram H, Liew S, Signorini M et al (2016) Global aesthetics consensus: hyaluronic acid fillers and botulinum toxin type A—recommendations for combined treatment and optimizing outcomes in diverse patient population. Plast Reconstr Surg 137:1410–1423CrossRefPubMedPubMedCentral
6.
go back to reference Carruthers J, Glogau RG, Blitzer A, Facial Aesthetics Consensus Group Faculty (2008) Advances in facial rejuvenation: botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies-consensus recommendations. Plast Reconstr Surg 121(5 Suppl):5S–30S (quiz 31S-36S) CrossRefPubMed Carruthers J, Glogau RG, Blitzer A, Facial Aesthetics Consensus Group Faculty (2008) Advances in facial rejuvenation: botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies-consensus recommendations. Plast Reconstr Surg 121(5 Suppl):5S–30S (quiz 31S-36S) CrossRefPubMed
7.
go back to reference Hexel DM, Klein AW (2010) Botulinum toxin. Section 51. In: Baran R, Maibach HI (eds) Textbook of cosmetic dermatology, 4th edn. Informa Healthcare, New York, pp 443–452 Hexel DM, Klein AW (2010) Botulinum toxin. Section 51. In: Baran R, Maibach HI (eds) Textbook of cosmetic dermatology, 4th edn. Informa Healthcare, New York, pp 443–452
8.
go back to reference Carruthers A, Carruthers J, Cohen J (2007) Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: Does it matter? Dermatol Surg 33:S97–S104CrossRefPubMed Carruthers A, Carruthers J, Cohen J (2007) Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: Does it matter? Dermatol Surg 33:S97–S104CrossRefPubMed
9.
go back to reference Carruthers J, Rivkin A, Donofrio L et al (2015) A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of repeated onabotulinumtoxinA treatments in subjects with crow’s feet lines and glabellar lines. Dermatol Surg 41(6):702–711CrossRefPubMed Carruthers J, Rivkin A, Donofrio L et al (2015) A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of repeated onabotulinumtoxinA treatments in subjects with crow’s feet lines and glabellar lines. Dermatol Surg 41(6):702–711CrossRefPubMed
10.
go back to reference Carruthers J, Fagien S, Matarasso SL, Botox Consensus Group (2004) Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg 114(6 Suppl):1S–22SCrossRefPubMed Carruthers J, Fagien S, Matarasso SL, Botox Consensus Group (2004) Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg 114(6 Suppl):1S–22SCrossRefPubMed
11.
go back to reference de Almeida AR, da Costa Marques ER, Banegas R, Kadunc BV (2012) Glabellar contraction patterns: a tool to optimize botulinum toxin treatment. Dermatol Surg 38(9):1506–1515CrossRefPubMed de Almeida AR, da Costa Marques ER, Banegas R, Kadunc BV (2012) Glabellar contraction patterns: a tool to optimize botulinum toxin treatment. Dermatol Surg 38(9):1506–1515CrossRefPubMed
12.
go back to reference Kaufman J, Green JB (2016) Injection techniques: forehead and eyebrow shaping. Chapter 3. In: Beer KR (ed) Handbook of botulinum toxins for aesthetic indications. Theory and practice. London, Philadelphia, Panama City, New Delhi: JP Medical, pp 15–22 Kaufman J, Green JB (2016) Injection techniques: forehead and eyebrow shaping. Chapter 3. In: Beer KR (ed) Handbook of botulinum toxins for aesthetic indications. Theory and practice. London, Philadelphia, Panama City, New Delhi: JP Medical, pp 15–22
13.
go back to reference Gart MS, Gutowski KA (2016) Overview of botulinum toxins for aesthetic uses. In: Rothaus KO (ed) Minimally invasive rejuvenation of face and neck. Elsevier, Philadelphia, pp 459–472 Gart MS, Gutowski KA (2016) Overview of botulinum toxins for aesthetic uses. In: Rothaus KO (ed) Minimally invasive rejuvenation of face and neck. Elsevier, Philadelphia, pp 459–472
14.
go back to reference Abramo AC, Dorta AA (2003) Selective myotomy in forehead endoscopy. Plast Reconstr Surg 112(3):873–879CrossRefPubMed Abramo AC, Dorta AA (2003) Selective myotomy in forehead endoscopy. Plast Reconstr Surg 112(3):873–879CrossRefPubMed
15.
go back to reference Rzany B, Ascher B, Fratila A et al (2016) Efficacy and safety and 3-and-5 injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and central forehead region. Arch Dermatol 142:320–326CrossRef Rzany B, Ascher B, Fratila A et al (2016) Efficacy and safety and 3-and-5 injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and central forehead region. Arch Dermatol 142:320–326CrossRef
16.
go back to reference Small R (2014) Botulinum toxin injection for facial wrinkles. Am Fam Physician 90(3):168–175PubMed Small R (2014) Botulinum toxin injection for facial wrinkles. Am Fam Physician 90(3):168–175PubMed
17.
go back to reference Maas C, Kane MA, Bucay VW et al (2012) Current aesthetic use of abobotulinumtoxinA in clinical practice: an evidence-based consensus review. Aesthet Surg J 32(1 Suppl):8S–29SCrossRefPubMed Maas C, Kane MA, Bucay VW et al (2012) Current aesthetic use of abobotulinumtoxinA in clinical practice: an evidence-based consensus review. Aesthet Surg J 32(1 Suppl):8S–29SCrossRefPubMed
Metadata
Title
Muscle Insertion and Strength of the Muscle Contraction as Guidelines to Enhance Duration of the Botulinum Toxin Effect in the Upper Face
Author
Antonio Carlos Abramo
Publication date
01-10-2018
Publisher
Springer US
Published in
Aesthetic Plastic Surgery / Issue 5/2018
Print ISSN: 0364-216X
Electronic ISSN: 1432-5241
DOI
https://doi.org/10.1007/s00266-018-1157-3

Other articles of this Issue 5/2018

Aesthetic Plastic Surgery 5/2018 Go to the issue